Since 16 May 2022, and as of 4 April 2023, 21 170 cases of mpox (formerly known as monkeypox) have been reported by countries within the European Union/European Economic Area (EU/EEA).
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing again to 15% positivity for week 14/2023.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 April 2023 and includes updates on mpox, Group A streptococcal, Influenza A(H5N1) infection, and Marburg virus disease.
To decrease the impact of COVID-19, and related hospitalisations and mortality, countries should plan for a continued roll-out of COVID vaccines in 2023.
This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the planning and implementation of COVID-19 vaccination campaigns for 2023.
The annual European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place in Barcelona and online from 22-24 November 2023.